Thrombotic Thrombocytopenic Purpura Pipeline Report - H1 2016 Review of 7 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Thrombotic Thrombocytopenic Purpura, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thrombotic Thrombocytopenic Purpura and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Thrombotic Thrombocytopenic Purpura Overview
  3. Therapeutics Development
  4. Pipeline Products for Thrombotic Thrombocytopenic Purpura - Overview
  5. Pipeline Products for Thrombotic Thrombocytopenic Purpura - Comparative Analysis
  6. Thrombotic Thrombocytopenic Purpura - Therapeutics under Development by Companies
  7. Thrombotic Thrombocytopenic Purpura - Therapeutics under Investigation by Universities/Institutes
  8. Thrombotic Thrombocytopenic Purpura Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Thrombotic Thrombocytopenic Purpura - Products under Development by Companies
  13. Thrombotic Thrombocytopenic Purpura - Products under Investigation by Universities/Institutes
  14. Thrombotic Thrombocytopenic Purpura - Companies Involved in Therapeutics Development
  • Ablynx NV
  • Biogen, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Kaketsuken K.K.
  • Lee's Pharmaceutical Holdings Limited
  • Octapharma AG
  • Omeros Corporation

For more information visit http://www.researchandmarkets.com/research/q57w9l/thrombotic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Hematological Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Hematological Drugs